Pharmaron Beijing

Historical price data

Pharmaron has established itself as a critical global infrastructure partner for pharmaceutical innovation, offering a fully integrated service portfolio from drug discovery through commercial manufacturing. Its strategy leverages a vertically integrated, modality-agnostic platform and a global operational footprint across China, the US, and the UK to capture the growing outsourcing trend. The company's achievements are reflected in its significant market valuation and its role in supporting hundreds of client programs, including complex biologics and novel therapeutic modalities, for a diverse international client base.

A fully integrated, modality-agnostic CRDMO platform offering end-to-end services from drug discovery and preclinical research through clinical development and commercial GMP manufacturing for small molecules, biologics, cell & gene therapies, ADCs, and protein degraders.

Pharmaron competes globally with large, integrated peers like WuXi AppTec, LabCorp, and IQVIA, as well as specialized CDMOs. Its competitive edge stems from a cost-effective China-based core with international quality, a true end-to-end integrated service model, and strategic Western acquisitions that provide global reach and client proximity.